DRUG DISPOSITION IN OBESE HUMANS - AN UPDATE

被引:153
作者
ABERNETHY, DR
GREENBLATT, DJ
机构
[1] TUFTS UNIV,SCH MED,DIV CLIN PHARMACOL,BOSTON,MA 02111
[2] NEW ENGLAND MED CTR,BOSTON,MA 02111
关键词
D O I
10.2165/00003088-198611030-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:199 / 213
页数:15
相关论文
共 75 条
[1]   IBUPROFEN DISPOSITION IN OBESE INDIVIDUALS [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
ARTHRITIS AND RHEUMATISM, 1985, 28 (10) :1117-1121
[2]   THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SMITH, RB ;
SHADER, RI .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :177-183
[3]   PROLONGATION OF DRUG HALF-LIFE DUE TO OBESITY - STUDIES OF DESMETHYLDIAZEPAM (CLORAZEPATE) [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SHADER, RI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) :942-944
[4]  
ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[5]  
ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
[6]   CAFFEINE DISPOSITION IN OBESITY [J].
ABERNETHY, DR ;
TODD, EL ;
SCHWARTZ, JB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (01) :61-66
[7]   OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION [J].
ABERNETHY, DR ;
DIVOLL, M ;
GREENBLATT, DJ ;
AMEER, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) :783-790
[8]  
ABERNETHY DR, 1984, CLIN PHARMACOL THER, V35, P224
[9]  
ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[10]   LIDOCAINE DISPOSITION IN OBESITY [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) :1183-1186